Search Results for: STEM CELL MARKET Stem Cell
Articles
STEM CELL MARKET - Stem Cell Therapy to Redefine Regenerative Medicine November 18, 2015
Jane C. Andrews, PhD, Frost & Sullivan Analyst, says faced with increasing challenges, such as costly treatments and treatments that are palliative rather than symptomatic, the global healthcare industry today is gradually transforming itself. With few existing therapies capable of curing or significantly changing the course of a disease, healthcare providers are starting to look toward regenerative medicine as a viable alternative.
Kincell Bio & Imugene Announce Strategic Manufacturing & Process Development Partnership April 16, 2024
Kincell Bio to acquire Imugene’s North Carolina manufacturing facility for up to $6M USD in upfront and milestone-driven payments over 3 years….
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion Into Autoimmune Diseases March 28, 2024
Mustang Bio, Inc. recently announced its expansion into autoimmune diseases with MB-106, a personalized CD20-targeted, 3rd-generation autologous CAR T-cell therapy....Bio-Rad Launches Validated Antibodies for Rare Cell & Circulating Tumor Cell Enumeration March 26, 2024
Bio-Rad Laboratories, Inc. recently announced the launch of validated antibodies for rare cell and circulating tumor cell (CTC) enumeration. Validated...Sequel’s twiist Automated Insulin Delivery System Receives FDA 510(k) Clearance March 18, 2024
Device bundles latest technology to deliver significant advancements for insulin management for people with type 1 diabetes….
GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T Cell Modulators March 14, 2024
GRI Bio, Inc. recently announced the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for Patent Application...ABVC's New Horizon for Oncology & Hematology Aims at Cancer Market of Several Hundred Billion Dollars February 27, 2024
ABVC BioPharma, Inc. recently provided an update on its development of combination therapy for the treatment of cancer and immunity booster dietary supplements. The company is currently marketing….
Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating its Next-Generation Vaccine Candidates Elicit Mucosal & Systemic Immunogenicity & Reduce Viral Shedding After SARS-CoV-2 Challenge February 5, 2024
Vaxart, Inc. recently announced the publication of preclinical non-human primate data demonstrating the potential of its COVID-19 vaccine to protect...Credence MedSystems Announces a Significant Milestone Toward Scaling Manufacturing Capabilties January 17, 2024
Credence MedSystems recently announced it has successfully completed Factory Acceptance Testing (FAT) for production of its Companion® injection device platform on the company’s new Clinical Assembly Line…..
Colorcon Unveils Corelease - A Unified Brand for Novel Controlled-Release Formulated Systems December 5, 2023
Ready formulated systems approach simplifies the development and manufacturing for controlled release…..
BIOLOGICS DEVELOPMENT - Five Steps to a Robust Cell Line Development Process October 2, 2023
Robert Gustines reviews the critical steps for designing and implementing a robust cell line development process to help overcome the obstacles that often hinder biologic production.
LIfT BioSciences Heralds a New Era of Affordable Effective Cancer Cell Therapies Simply Produced From iPSCs July 6, 2023
LIfT BioSciences recently announced successful proof-of-concept production of its patented cancer killing alpha neutrophils from induced….
Akari Therapeutics Receives Positive Opinion on Orphan Drug Designation From EMA for Nomacopan for Treatment in Hematopoietic Stem Cell Transplantation July 6, 2023
Akari Therapeutics, Plc recently announced the European Medicines Agency (EMA) has issued a positive opinion on the company’s application for...Croda Announces Two New Partnerships to Drive Sustainable Delivery Systems for the Pharmaceutical Industry June 20, 2023
Croda International Plc recently announced it has signed two new partnership agreements that will help the pharmaceutical industry move toward a more sustainable supply chain for vaccine adjuvants…..
Stevanato Group Presents Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies & for Large Delivery Volumes June 12, 2023
The company offers the platform as a readily customizable pre-filled and pre-loaded on-body solution for drug delivery. Device development is making significant progress, with samples expected to be available in 2023…..
BriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp. May 25, 2023
BriaCell Therapeutics Corp. recently announce it has entered into an arrangement agreement dated May 24, 2023, with BriaPro Therapeutics Corp....Cell & Gene Therapy CDMO Targets North American Growth With Major US Acquisition May 19, 2023
uBriGene is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc. The cell & gene therapy (CGT) CDMO has an….
First on the Market: Safely Storing Deep-Cold Medications With Prefillable Polymer Syringes From SCHOTT Pharma May 17, 2023
SCHOTT Pharma’s prefillable polymer syringes are a trailblazing solution for drug applications that need to be stored and transported on dry ice at temperatures approaching -100°C…..
Cellular Origins Partners With ScaleReady to Simplify, Standardize & Automate Cell Therapy Manufacturing May 11, 2023
Cellular Origins recently announced a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf that brings together process development expertise, tools, and technologies for scalable CGT….